H.‐Christian von Büdingen

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

Ari Green, Jeffrey M. Gelfand, Bruce Cree et al. · The Lancet · 2017 · 548 citations · Full text

Crossover Trial, Neurological Disorder, Neurological Progress +9

Long‐term evolution of multiple sclerosis disability in the treatment era

Bruce Cree, Pierre‐Antoine Gourraud, Carolyn Bevan et al. · Annals of Neurology · 2016 · 430 citations · Full text

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery

Feng Mei, Klaus Lehmann‐Horn, Yun‐An Shen et al. · eLife · 2016 · 308 citations · Full text

Inflammatory Demyelination, Immunology, Peripheral Nerves +17

Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients

Arumugam Palanichamy, Sarah Jahn, Dorothee Nickles et al. · The Journal of Immunology · 2014 · 280 citations

B cell exchange across the blood-brain barrier in multiple sclerosis

H.‐Christian von Büdingen, Tracy C. Kuo, Marina Sirota et al. · Journal of Clinical Investigation · 2012 · 231 citations · Full text

Adaptive Immune System, Neurological Disorder, Immunology +21